$PMDI
PSYCHEMEDICS CORP Stock $pmdi

$pmdi Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000117184321005903 Filed on August 12, 2021

Income Statement

Concept	2021 Q2	2020 Q2	2020 Q1
Revenue	$6.087M	$3.314M	$7.537M
YoY Change	83.68%	-64.32%	-23.26%
Cost Of Revenue	$3.651M	$3.566M	$4.809M
YoY Change	2.38%	-30.35%	-11.17%
Gross Profit	$2.436M	-$252.0K	$2.728M
YoY Change	-1066.67%	-106.04%	-38.11%
Gross Profit Margin	40.02%	-7.6%	36.19%
Selling, General & Admin	$1.936M	$2.709M	$2.639M
YoY Change	-28.53%	10.89%	-13.3%
% of Gross Profit	79.47%		96.74%
Research & Development	$293.0K	$345.0K	$331.0K
YoY Change	-15.07%	-13.75%	-21.19%
% of Gross Profit	12.03%		12.13%
Depreciation & Amortization	$663.0K	$680.0K	$610.0K
YoY Change	-2.5%	-8.11%	-20.16%
% of Gross Profit	27.22%		22.36%
Operating Expenses	$2.229M	$3.054M	$2.970M
YoY Change	-27.01%	7.42%	-14.26%
Operating Profit	$207.0K	-$3.306M	-$242.0K
YoY Change	-106.26%	-349.32%	-125.64%
Interest Expense	-$13.00K	-$40.00K	-$70.00K
YoY Change	-67.5%	-300.0%	-511.76%
% of Operating Profit	-6.28%
Other Income/Expense, Net	$0.00	-$39.00K	-$73.00K
YoY Change	-100.0%	-277.27%	-380.77%
Pretax Income	$207.0K	-$3.345M	-$315.0K
YoY Change	-106.19%	-348.15%	-132.47%
Income Tax	$73.00K	-$1.295M	-$156.0K
% Of Pretax Income	35.27%
Net Earnings	$134.0K	-$2.050M	-$159.0K
YoY Change	-106.54%	-366.93%	-125.36%
Net Earnings / Revenue	2.2%	-61.86%	-2.11%
Basic Earnings Per Share	$0.02	-$0.37	-$0.03
Diluted Earnings Per Share	$0.02	-$0.37	-$0.03
COMMON SHARES
Basic Shares Outstanding	5.539M	5.523M	5.517M
Diluted Shares Outstanding	5.627M	5.523M	5.517M

Balance Sheet

Concept	2021 Q2	2020 Q2	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.651M	$3.670M	$5.330M
YoY Change	-27.77%	-48.29%	-25.35%
Cash & Equivalents	$2.700M	$3.672M	$5.331M
Short-Term Investments
Other Short-Term Assets	$2.575M	$1.500M	$1.890M
YoY Change	71.67%	-11.76%	57.5%
Inventory
Prepaid Expenses
Receivables	$3.971M	$2.560M	$3.558M
Other Receivables	$2.539M	$2.030M	$0.00
Total Short-Term Assets	$11.74M	$9.754M	$10.78M
YoY Change	20.32%	-26.79%	-20.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.993M	$10.37M	$10.89M
YoY Change	-22.95%	9.17%	13.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$849.0K	$920.0K	$936.0K
YoY Change	-7.72%	3.02%	3.88%
Total Long-Term Assets	$12.85M	$16.02M	$14.43M
YoY Change	-19.79%	35.64%	19.71%
TOTAL ASSETS
Total Short-Term Assets	$11.74M	$9.754M	$10.78M
Total Long-Term Assets	$12.85M	$16.02M	$14.43M
Total Assets	$24.59M	$25.78M	$25.21M
YoY Change	-4.61%	2.55%	-1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.100M	$61.00K	$1.234M
YoY Change	1703.28%	-91.34%	226.46%
Accrued Expenses	$1.890M	$1.649M	$2.113M
YoY Change	14.61%	-25.72%	-19.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$693.0K	$683.0K	$680.0K
YoY Change	1.46%	64.18%	63.46%
Total Short-Term Liabilities	$4.648M	$3.283M	$4.913M
YoY Change	41.58%	-21.85%	12.4%
LONG-TERM LIABILITIES
Long-Term Debt	$3.096M	$3.789M	$1.780M
YoY Change	-18.29%	277.01%	60.5%
Other Long-Term Liabilities	$3.490M	$4.300M	$2.210M
YoY Change	-18.84%	667.86%	240.0%
Total Long-Term Liabilities	$3.096M	$3.789M	$1.780M
YoY Change	-18.29%	277.01%	60.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.648M	$3.283M	$4.913M
Total Long-Term Liabilities	$3.096M	$3.789M	$1.780M
Total Liabilities	$11.47M	$11.85M	$9.402M
YoY Change	-3.21%	78.01%	33.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.389M	-$6.956M	-$4.906M
YoY Change	20.6%	263.05%	190.3%
Common Stock	$33.22M	$32.60M	$32.44M
YoY Change	1.92%	2.37%	2.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.08M	$10.08M	$10.08M
YoY Change	0.0%	0.0%	0.0%
Treasury Stock Shares	$668.0K	$668.0K	$668.0K
Shareholders Equity	$13.12M	$13.92M	$15.81M
YoY Change
Total Liabilities & Shareholders Equity	$24.59M	$25.78M	$25.21M
YoY Change	-4.61%	2.55%	-1.25%

Cashflow Statement

Concept	2021 Q2	2020 Q2	2020 Q1
OPERATING ACTIVITIES
Net Income	$134.0K	-$2.050M	-$159.0K
YoY Change	-106.54%	-366.93%	-125.36%
Depreciation, Depletion And Amortization	$663.0K	$680.0K	$610.0K
YoY Change	-2.5%	-8.11%	-20.16%
Cash From Operating Activities	$647.0K	-$3.320M	-$413.0K
YoY Change	-119.49%	-351.52%	-212.23%
INVESTING ACTIVITIES
Capital Expenditures	-$34.00K	-$340.0K	$401.0K
YoY Change	-90.0%	47.83%	1809.52%
Acquisitions
YoY Change
Other Investing Activities	$18.00K	$0.00	$7.000K
YoY Change		-100.0%	-143.75%
Cash From Investing Activities	-$16.00K	-$350.0K	-$333.0K
YoY Change	-95.43%	-109.78%	197.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-173.0K	2.000M	-1.162M
YoY Change	-108.65%	-276.99%	6.12%
NET CHANGE
Cash From Operating Activities	647.0K	-3.320M	-413.0K
Cash From Investing Activities	-16.00K	-350.0K	-333.0K
Cash From Financing Activities	-173.0K	2.000M	-1.162M
Net Change In Cash	458.0K	-1.670M	-1.952M
YoY Change	-127.43%	-144.3%	132.66%
FREE CASH FLOW
Cash From Operating Activities	$647.0K	-$3.320M	-$413.0K
Capital Expenditures	-$34.00K	-$340.0K	$401.0K
Free Cash Flow	$681.0K	-$2.980M	-$814.0K
YoY Change	-122.85%	-292.26%	-334.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5542232
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	37000	USD
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	18529000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16937000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	873000
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6209000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6205000
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5541000
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5537000
CY2021Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	668000
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	550000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2651000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2833000	USD
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3971000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3356000	USD
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2575000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	914000	USD
CY2021Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2539000	USD
CY2020Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2495000	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	11736000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	9598000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7993000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9231000	USD
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	849000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	888000	USD
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4009000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4286000	USD
CY2021Q2	us-gaap	Assets Assets	24587000	USD
CY2020Q4	us-gaap	Assets Assets	24003000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1100000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	577000	USD
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1890000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1801000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	693000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	688000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	965000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	875000	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4648000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3941000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3096000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3444000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	238000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	211000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3490000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3895000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	11472000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	11491000	USD
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	31000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	33189000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32803000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8389000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8606000	USD
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10082000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1634000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24587000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24003000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6087000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3314000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11800000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10851000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3651000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3566000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6796000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8375000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	2436000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	-252000	USD
	us-gaap	Gross Profit GrossProfit	5004000	USD
	us-gaap	Gross Profit GrossProfit	2476000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1280000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1853000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2809000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3386000	USD
CY2021Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	656000	USD
CY2020Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	856000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1298000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1962000	USD
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	293000	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	345000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	573000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	676000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2229000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	3054000	USD
	us-gaap	Operating Expenses OperatingExpenses	4680000	USD
	us-gaap	Operating Expenses OperatingExpenses	6024000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	207000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-3306000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	324000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3548000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-39000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-112000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	207000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3345000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	310000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3660000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1295000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	93000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1451000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	134000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2050000	USD
	us-gaap	Net Income Loss NetIncomeLoss	217000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2209000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	13000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	0	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-10000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	134000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2037000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	217000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2219000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	12812000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	169000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	134000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	12512000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	386000	USD
	us-gaap	Net Income Loss NetIncomeLoss	217000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	13115000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	15808000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	USD
CY2020Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	160000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2050000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	14000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	13924000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	16820000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	-0	USD
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	8000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	323000	USD
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	993000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2209000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-9000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	13924000	USD
	us-gaap	Net Income Loss NetIncomeLoss	217000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2209000	USD
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1353000	USD
	pmd	Depreciation And Amortization Excluding Rou Asset Amortization DepreciationAndAmortizationExcludingRouAssetAmortization	1288000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	470000	USD
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	493000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-27000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	74000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-94000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	386000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	323000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	615000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1220000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1661000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	190000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	44000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	1544000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	523000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-556000	USD
	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-508000	USD
	pmd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-490000	USD
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	89000	USD
	pmd	Increase Decrease In Accrued Expenses And Accrued Income Taxes IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes	-2084000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	237000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3729000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	140000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	675000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	70000	USD
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	135000	USD
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	-8000	USD
	pmd	Payments For Proceeds From Other Assets PaymentsForProceedsFromOtherAssets	7000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-677000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-8000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2181000	USD
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	343000	USD
	pmd	Payments Of Equipment Financing PaymentsOfEquipmentFinancing	338000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	-0	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	993000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-343000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	842000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-182000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3611000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2833000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7283000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2651000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3672000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	229000	USD
	us-gaap	Interest Paid Net InterestPaidNet	28000	USD
	us-gaap	Interest Paid Net InterestPaidNet	43000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	575000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	519000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	193000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2346000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	193000	USD
CY2021Q2	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	800000	USD
	pmd	Income Tax Benefit Cares Act IncomeTaxBenefitCARESAct	1600000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2700000	USD
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	169000	USD
CY2020Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	160000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	386000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	323000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	604000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.31
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.47
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	575000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.23
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	98000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	464000
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.12
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y2M12D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5539000
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5523000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5538000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5520000
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	88000
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	83000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5627000
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5523000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5621000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5520000
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	550000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4000000.0	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4500000	USD
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	269000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	538000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	532000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1117000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1118000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1034000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	592000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	460000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4853000	USD
CY2021Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	398000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4455000	USD
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	965000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3490000	USD
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4455000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3096000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6087000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3314000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11800000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10851000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6087000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3314000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11800000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	10851000	USD

Files In Submission

Name	View Source	Status
0001171843-21-005903-index-headers.html	Edgar Link	pending
0001171843-21-005903-index.html	Edgar Link	pending
0001171843-21-005903.txt	Edgar Link	pending
0001171843-21-005903-xbrl.zip	Edgar Link	pending
ex_272730.htm	Edgar Link	pending
ex_272731.htm	Edgar Link	pending
ex_272732.htm	Edgar Link	pending
ex_272733.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pmd-20210630.xsd	Edgar Link	pending
pmd-20210630_cal.xml	Edgar Link	unprocessable
pmd-20210630_def.xml	Edgar Link	unprocessable
pmd-20210630_lab.xml	Edgar Link	unprocessable
pmd-20210630_pre.xml	Edgar Link	unprocessable
pmd20210630_10q.htm	Edgar Link	pending
pmd20210630_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PMDI
PSYCHEMEDICS CORP Stock $pmdi

2021 Q2 Form 10-Q Financial Statement

#000117184321005903 Filed on August 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI PSYCHEMEDICS CORP Stock $pmdi

2021 Q2 Form 10-Q Financial Statement

#000117184321005903 Filed on August 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PMDI
PSYCHEMEDICS CORP Stock $pmdi